oa Towards ‘Eternal Youth’ of cardiac and skeletal muscle

References

1. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 2006; 355::251–259.
   [Google الباحث العلمي]
2. Holland DJ, Kumbhani DJ, Ahmed SH, Marwick TH. Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis. J. Am. Coll. Cardiol. 2011; 57::1676–1686.
   [Google الباحث العلمي]
3. ElGuindy A, Yacoub M. Review article: Heart Failure with Preserved Ejection Fraction. Glob. Cardiol. Sci. Pract. 2012;10.
   [Google الباحث العلمي]
4. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, CHARM Investigators and Committees . Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003; 362::777–781.
   [Google الباحث العلمي]
5. Cleland JGF, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur. Heart J. 2006; 27::2338–2345.
   [Google الباحث العلمي]
6. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A, I-PRESERVE Investigators . Irbesartan in patients with heart failure and preserved ejection fraction. N. Engl. J. Med. 2008; 359::2456–2467.
   [Google الباحث العلمي]
7. Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O'Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM, TOPCAT Investigators . Spironolactone for heart failure with preserved ejection fraction. N. Engl. J. Med. 2014; 370::1383–1392.
   [Google الباحث العلمي]
8. Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, Hernandez AF, Fonarow GC. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation. 2012; 126::65–75.
   [Google الباحث العلمي]
9. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, Rutledge JE, Boineau RC. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J. Am. Coll. Cardiol. 2000; 35::1628–1637.
   [Google الباحث العلمي]
10. Borlaug B, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J. Am. Coll. Cardiol. 2010; 56::845–854.
    [Google الباحث العلمي]
11. Maurer MS, Hummel SL. Heart failure with a preserved ejection fraction: what is in a name? J. Am. Coll. Cardiol. 2011; 58::275–277.
    [Google الباحث العلمي]
12. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation. 2003; 107::346–354.
    [Google الباحث العلمي]
13. Bhella PS, Prasad A, Heinicke K, Hastings JL, Arbab-Zadeh A, Adams-Huet B, Pacini EL, Shibata S, Palmer MD, Newcomer BR, Levine BD. Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur. J. Heart Fail. 2011; 13::1296–1304.
    [Google الباحث العلمي]
14. Nicklas BJ, Leng I, Delbono O, Kitzman DW, Marsh AP, Hundley WG, Lyles MF, O'Rourke KS, Annex BH, Kraus WE. Relationship of physical function to vastus lateralis capillary density and metabolic enzyme activity in elderly men and women. Aging Clin. Exp. Res. 2008; 20::302–309.
    [Google الباحث العلمي]
15. Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J. Am. Coll. Cardiol. 2011; 58::265–274.
    [Google الباحث العلمي]
16. Haykowsky MJ, Brubaker PH, Morgan TM, Kritchevsky S, Eggebeen J, Kitzman DW. Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass. J. Gerontol. A. Biol. Sci. Med. Sci. 2013; 68::968–975.
    [Google الباحث العلمي]
17. Westermann D, Lindner D, Kasner M, Zietsch C, Savvatis K, Escher F, von Schlippenbach J, Skurk C, Steendijk P, Riad A, Poller W, Schultheiss HP, Tschöpe C. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ. Heart Fail. 2011; 4::44–52.
    [Google الباحث العلمي]
18. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA. 2002; 288::2144–2150.
    [Google الباحث العلمي]
19. Clarkson PB, Wheeldon NM, MacFadyen RJ, Pringle SD, MacDonald TM. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure. Circulation. 1996; 93::2037–2042.
    [Google الباحث العلمي]
20. Maurer MS, Burkhoff D, Fried LP, Gottdiener J, King DL, Kitzman DW. Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J. Am. Coll. Cardiol. 2007; 49::972–981.
    [Google الباحث العلمي]
21. Brubaker PH, Joo KC, Stewart KP, Fray B, Moore B, Kitzman DW. Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. J. Cardiopulm. Rehabil. 2006; 26::86–89.
    [Google الباحث العلمي]
22. Guazzi M, Vicenzi M, Arena R, Guazzi MD. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation. 2011; 124::164–174.
    [Google الباحث العلمي]
23. Kawaguchi M. Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations. Circulation. 2003; 107::714–720.
    [Google الباحث العلمي]
24. Frenneaux M, Williams L. Ventricular-arterial and ventricular-ventricular interactions and their relevance to diastolic filling. Prog. Cardiovasc. Dis. 2007; 49::252–262.
    [Google الباحث العلمي]
25. Hundley WG, Bayram E, Hamilton CA, Hamilton EA, Morgan TM, Darty SN, Stewart KP, Link KM, Herrington DM, Kitzman DW. Leg flow-mediated arterial dilation in elderly patients with heart failure and normal left ventricular ejection fraction. Am. J. Physiol. Heart Circ. Physiol. 2007; 292::H1427–H1434.
    [Google الباحث العلمي]
26. Borlaug B, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC, Kass DA. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation. 2006; 114::2138–2147.
    [Google الباحث العلمي]
27. Loffredo FS, Steinhauser ML, Jay SM, Gannon J, Pancoast JR, Yalamanchi P, Sinha M, Dall'Osso C, Khong D, Shadrach JL, Miller CM, Singer BS, Stewart A, Psychogios N, Gerszten RE, Hartigan AJ, Kim MJ, Serwold T, Wagers AJ, Lee RT. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013; 153::828–839.
    [Google الباحث العلمي]
28. Frank KF, Bölck B, Brixius K, Kranias EG, Schwinger RH. Modulation of SERCA: implications for the failing human heart. Basic Res. Cardiol. 2002; 97:Suppl 1:I72–I78.
    [Google الباحث العلمي]
29. Del Monte F, Harding SE, Dec GW, Gwathmey JK, Hajjar RJ. Targeting phospholamban by gene transfer in human heart failure. Circulation. 2002; 105::904–907.
    [Google الباحث العلمي]
30. MacLennan DH, Kranias EG. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 2003; 4::566–577.
    [Google الباحث العلمي]
31. Hasenfuss G. Calcium Cycling in Congestive Heart Failure. J. Mol. Cell. Cardiol. 2002; 34::951–969.
    [Google الباحث العلمي]
32. Govinden R, Bhoola KD. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol. Ther. 2003; 98::257–265.
    [Google الباحث العلمي]
33. Lara-Pezzi E, Felkin LE, Birks EJ, Sarathchandra P, Panse KD, George R, Hall JL, Yacoub MH, Rosenthal N, Barton PJ. Expression of follistatin-related genes is altered in heart failure. Endocrinology. 2008; 149::5822–5827.
    [Google الباحث العلمي]
34. Rando TA, Finkel T. Cardiac aging and rejuvenation–a sense of humors? N. Engl. J. Med. 2013; 369::575–576.
    [Google الباحث العلمي]
35. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J. Am. Geriatr. Soc. 2002; 50::889–896.
    [Google الباحث العلمي]
36. Szulc P, Beck TJ, Marchand F, Delmas PD. Low skeletal muscle mass is associated with poor structural parameters of bone and impaired balance in elderly men–the MINOS study. J. Bone Miner. Res. 2005; 20::721–729.
    [Google الباحث العلمي]
37. Arthur ST, Cooley ID. The effect of physiological stimuli on sarcopenia; impact of Notch and Wnt signaling on impaired aged skeletal muscle repair. Int. J. Biol. Sci. 2012; 8::731–760.
    [Google الباحث العلمي]
38. Renault V, Thornell LE, Eriksson PO, Butler-Browne G, Mouly V. Regenerative potential of human skeletal muscle during aging. Aging Cell. 2002; 1::132–139.
    [Google الباحث العلمي]
39. Coats AJ. The “muscle hypothesis” of chronic heart failure. J. Mol. Cell. Cardiol. 1996; 28::2255–2262.
    [Google الباحث العلمي]
40. Piepoli MF, Coats AJS. The “skeletal muscle hypothesis in heart failure” revised. Eur. Heart J. 2013; 34::486–488.
    [Google الباحث العلمي]
41. Bunout D, de la Maza MP, Barrera G, Leiva L, Hirsch S. Association between sarcopenia and mortality in healthy older people. Australas. J. Ageing. 2011; 30::89–92.
    [Google الباحث العلمي]
42. Krakauer JC, Franklin B, Kleerekoper M, Karlsson M, Levine JA. Body composition profiles derived from dual-energy X-ray absorptiometry, total body scan, and mortality. Prev. Cardiol. 2004; 7::109–115.
    [Google الباحث العلمي]
43. Kuang S, Kuroda K, Le Grand F, Rudnicki MA. Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell. 2007; 129::999–1010.
    [Google الباحث العلمي]
44. Troy A, Cadwallader AB, Fedorov Y, Tyner K, Tanaka KK, Olwin BB. Coordination of satellite cell activation and self-renewal by Par-complex-dependent asymmetric activation of p38α/β MAPK. Cell Stem Cell. 2012; 11::541–553.
    [Google الباحث العلمي]
45. Bernet JD, Doles JD, Hall JK, Kelly Tanaka K, Carter TA, Olwin BB. p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice. Nat. Med. 2014; 20::265–271.
    [Google الباحث العلمي]
46. Chakkalakal JV, Jones KM, Basson MA, Brack AS. The aged niche disrupts muscle stem cell quiescence. Nature. 2012; 490::355–360.
    [Google الباحث العلمي]
47. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005; 433::760–764.
    [Google الباحث العلمي]
48. Sousa-Victor P, Gutarra S, García-Prat L, Rodriguez-Ubreva J, Ortet L, Ruiz-Bonilla V, Jardí M, Ballestar E, González S, Serrano AL, Perdiguero E, Muñoz-Cánoves P. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature. 2014; 506::316–321.
    [Google الباحث العلمي]
49. Li M, Izpisua Belmonte JC. Ageing: Genetic rejuvenation of old muscle. Nature. 2014; 506::304–305.
    [Google الباحث العلمي]
50. Price FD, von Maltzahn J, Bentzinger CF, Dumont NA, Yin H3, Chang NC, Wilson DH, Frenette J, Rudnicki MA. Inhibition of JAK-STAT signaling stimulates adult satellite cell function. Nat. Med. 2014; 20::1174–1181.
    [Google الباحث العلمي]
51. Tierney MT, Aydogdu T, Sala D, Malecova B, Gatto S, Puri PL, Latella L, Sacco A. STAT3 signaling controls satellite cell expansion and skeletal muscle repair. Nat. Med. 2014; 20::1182–1186.
    [Google الباحث العلمي]
52. Doles JD, Olwin BB. The impact of JAK-STAT signaling on muscle regeneration. Nat. Med. 2014; 20::1094–1095.
    [Google الباحث العلمي]
53. Sinha M, Jang YC, Oh J, Khong D, Wu EY, Manohar R, Miller C, Regalado SG, Loffredo FS, Pancoast JR, Hirshman MF, Lebowitz J, Shadrach JL, Cerletti M, Kim MJ, Serwold T, Goodyear LJ, Rosner B, Lee RT, Wagers AJ. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science. 2014; 344::649–652.
    [Google الباحث العلمي]